| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1460-9568.2009.06613.X |
| P698 | PubMed publication ID | 19187266 |
| P2093 | author name string | Susan Wonnacott | |
| Cecilia Gotti | |||
| Milena Moretti | |||
| James N C Kew | |||
| Lee A Dawson | |||
| Mohammed Shoaib | |||
| Jayaraman Srinivasan | |||
| Phil D Livingstone | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 539-550 | |
| P577 | publication date | 2009-01-28 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex | |
| P478 | volume | 29 |
| Q37962995 | A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia |
| Q35035848 | A role for glutamate in subjective response to smoking and its action on inhibitory control |
| Q38495197 | Acute nicotine enhances strategy-based semantic processing in Parkinson's disease |
| Q36573029 | Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex |
| Q24627240 | Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology |
| Q38286122 | Annual research review: Rare genotypes and childhood psychopathology--uncovering diverse developmental mechanisms of ADHD risk |
| Q33930536 | Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication |
| Q37643422 | Behavioral and Biochemical Interaction Between Nicotine and Chronic Unpredictable Mild Stress in Mice |
| Q37188764 | Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment |
| Q90615597 | Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats |
| Q50056855 | Drosophila as a Model System for Neurotransmitter Measurements |
| Q26744718 | Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies |
| Q46490757 | Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats |
| Q50676033 | Effect of varenicline on aspects of inhibitory control in smokers. |
| Q36652326 | Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history |
| Q48124586 | Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes |
| Q37601479 | Emerging cognitive enhancing drugs |
| Q30428422 | Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia |
| Q34997975 | Glutamate-dopamine crosstalk in the rat prefrontal cortex is modulated by Alpha7 nicotinic receptors and potentiated by PNU-120596. |
| Q91857043 | Impact of modulation of the α7 nicotinic acetylcholine receptor on nicotine reward in the mouse conditioned place preference test |
| Q36451065 | Impact of prefrontal cortex in nicotine-induced excitation of ventral tegmental area dopamine neurons in anesthetized rats |
| Q41960233 | Integration of inhibitory and excitatory effects of α7 nicotinic acetylcholine receptor activation in the prelimbic cortex regulates network activity and plasticity. |
| Q50770547 | Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice. |
| Q35421107 | Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study |
| Q27687645 | Mechanistic insights into nicotine withdrawal |
| Q34127939 | Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptors. |
| Q60046151 | Neurobiological Determinants of Tobacco Smoking in Schizophrenia |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q28082026 | Nicotine and the adolescent brain |
| Q36554456 | Nicotine exposure during adolescence leads to short- and long-term changes in spike timing-dependent plasticity in rat prefrontal cortex |
| Q37629127 | Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex. |
| Q36828916 | Nicotinic receptors in neurodegeneration |
| Q37590093 | Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system |
| Q38815903 | Nicotinic α4β2 Cholinergic Receptor Influences on Dorsolateral Prefrontal Cortical Neuronal Firing during a Working Memory Task. |
| Q48582261 | Orbitofrontal participation in sign- and goal-tracking conditioned responses: Effects of nicotine |
| Q48767121 | PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats. |
| Q33870433 | Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence |
| Q33830056 | Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling |
| Q37976289 | Prefrontal neuromodulation by nicotinic receptors for cognitive processes. |
| Q37862242 | Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment |
| Q41921130 | Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats |
| Q36088364 | The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia |
| Q34582381 | The effect of combined glutamate receptor blockade in the NTS on the hypoxic ventilatory response in awake rats differs from the effect of individual glutamate receptor blockade |
| Q47848449 | The effects of nicotine in the neonatal quinpirole rodent model of psychosis: Neural plasticity mechanisms and nicotinic receptor changes |
| Q34154675 | The frequency-dependence of the nicotine-induced inhibition of dopamine is controlled by the α7 nicotinic receptor |
| Q42629750 | The impact of cafeteria diet feeding on physiology and anxiety-related behaviour in male and female Sprague-Dawley rats of different ages |
| Q27013979 | The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition |
| Q41937423 | Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment |
| Q34581117 | Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors |
| Q37465460 | nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. |
| Q30362464 | nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. |
| Q37346227 | α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability |
Search more.